Skip to content

Pulmonary Hypertension Biorepository and Registry

Pulmonary Hypertension Biorepository and Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04808596
Acronym
PHBR
Enrollment
300
Registered
2021-03-22
Start date
2020-08-10
Completion date
2027-07-31
Last updated
2025-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Pulmonary Hypertension Due to Left Heart Disease, Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension, Primary, Pulmonary Hypertension, Primary, 2, Pulmonary Hypertension, Primary, 3, Pulmonary Hypertension, Primary, 4

Brief summary

Establish a pulmonary hypertension registry and biorepository to lead towards a further understanding of the disease.

Detailed description

The aim of this project will be to establish a broad and wide-ranging registry and biorepository of blood samples from patients with pulmonary hypertension, including all WHO groups I-V to be used for future research in these areas. This will be both a retrospective and prospective project. The registry and biorepository will be utilized to study and grow our knowledge of the cellular mechanisms and mediators of the disease and, in turn, contribute to advancements in treatment.

Interventions

None listed

Sponsors

University of Kansas Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

1. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP) 2. The participant has a diagnosis of pulmonary hypertension confirmed by right heart catheterization 3. Patient is ≥ 18 years of age or older

Exclusion criteria

1. Participant declines to participate (living patients only) 2. Participant is unable to provide informed consent (living patients only)

Design outcomes

Primary

MeasureTime frameDescription
Collect Clinical DataFrom Enrollment to 6 MonthsCollect clinically obtained data from current and deceased patients with pulmonary hypertension to support research.
Establish a BiorepositoryFrom Enrollment to 6 MonthsEstablish a collection of biospecimens from patients with pulmonary hypertension.
Biospecimens CollectionFrom Enrollment to 12 MonthsCorrelate biospecimens to longitudinally collected individual patient data.
CollaborateFrom Enrollment to 24 MonthsProvide biospecimens to researchers investigating pulmonary hypertension. Separate IRB approval will be needed for these studies.

Countries

United States

Contacts

Primary ContactLuigi R Boccardi, Ed.D., MPH
lboccardi@kumc.edu9135884022
Backup ContactKimberly Cygan, MBA, BSN, RN
kcygan@kumc.edu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026